Lourdes Weltzien - Nov 4, 2021 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC (VIVO)

Role
EVP, Life Science
Signature
/s/ Bryan T. Baldasare as Attorney-in-Fact for Lourdes G. Weltzien
Stock symbol
VIVO
Transactions as of
Nov 4, 2021
Transactions value $
$0
Form type
4
Date filed
11/8/2021, 03:12 PM
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Award $0 +10.6K +13.75% $0.00 87.6K Nov 4, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVO Stock Options (Right to Buy) Award $0 +11.7K $0.00 11.7K Nov 4, 2021 Common Stock 11.7K $18.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on November 4, 2025).
F2 These non-qualified options are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the options awarded vest on November 4, 2022; and (ii) the remaining 75% of the options awarded vest pro rata each month from November 4, 2022 through November 4, 2025.